---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-116217"
form_type: "8-K"
ticker: "IRWD"
cik: "0001446847"
company_name: "IRONWOOD PHARMACEUTICALS INC"
filed_at: "2025-11-26T23:59:59+00:00"
generated_at: "2026-05-16T16:27:08.689585+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# HHS sets LINZESS Maximum Fair Price at $136 per 30-day supply starting Jan 2027

## Summary
- MFP for LINZESS (linaclotide) is $136 for a 30-day supply, effective January 1, 2027.
- Ironwood says the MFP is in line with company expectations.
- LINZESS was selected in the latest round of IRA government price setting.
- MFP will become the new Medicare net price for the drug.

## SEC filing metadata
- accession: 0001104659-25-116217
- form_type: 8-K
- ticker: IRWD
- cik: 0001446847
- company_name: IRONWOOD PHARMACEUTICALS INC
- filed_at: 2025-11-26T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446847/000110465925116217/0001104659-25-116217-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446847/000110465925116217/tm2532096d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-116217
- JSON: https://secwatch.observer/filing/0001104659-25-116217.json
- Plain text: https://secwatch.observer/filing/0001104659-25-116217.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.